| Synonyms: | |
| Status: | Approved (2020) |
| Entry Type: | Oligonucleotide |
| Molecule Category: | UNKNOWN |
| ATC: | A16AX18 |
| UNII: | RZT8C352O1 |
Pharmacology
| Action | Mechanism of Action | Reference |
|---|---|---|
| RNAI INHIBITOR | Hydroxyacid oxidase 1 mRNA RNAi inhibitor | FDA |
Indications
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Hyperoxaluria, Primary | 3 | D006960 | ClinicalTrials |
| Hyperoxaluria, Primary | 3 | D006960 | ClinicalTrials |
Cross References
| Resources | Reference |
|---|---|
| ChEMBL | CHEMBL4297779 |
| FDA SRS | RZT8C352O1 |
CONTENTS